Leo A. van der Pol

Inactivated polio vaccine development for technology transfer using attenuated Sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV

Wilfried A.M. Bakker, Yvonne E. Thomassen, Aart G. van’t Oever et al. · Vaccine · 2011 · 92 citations

Vaccination, Cell-based Vaccine Production, Polio Vaccine Development +8

Cysteine Depletion Causes Oxidative Stress and Triggers Outer Membrane Vesicle Release by Neisseria meningitidis; Implications for Vaccine Development

Bas van de Waterbeemd, G. Zomer, Jan van den IJssel et al. · PLoS ONE · 2013 · 89 citations · Full text

Microbial Pathogens, Immunology, Innate Immunity +20

Modeling Neisseria meningitidis metabolism: from genome to metabolic fluxes

Gino Baart, Bert Zomer, Alex de Haan et al. · Genome biology · 2007 · 78 citations · Full text

Improved Production Process for Native Outer Membrane Vesicle Vaccine against Neisseria meningitidis

Bas van de Waterbeemd, G. Zomer, Patricia Kaaijk et al. · PLoS ONE · 2013 · 68 citations · Full text

Vaccination, Mucosal Vaccination, Vaccine Development +14

Quantitative Proteomics Reveals Distinct Differences in the Protein Content of Outer Membrane Vesicle Vaccines

Bas van de Waterbeemd, Geert P. M. Mommen, Jeroen L. A. Pennings et al. · Journal of Proteome Research · 2013 · 66 citations

Vaccination, Protein Content, Proteomic Technology +15